HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.

Abstract
Oestrogen and progesterone receptor assays were performed in 286 women with primary breast cancer, and the patient group was followed up for a minimum of 24 months. Of the 263 patients belonging to clinical stages I-III and serving as the population used for calculation of disease-free interval only 1.9% received postoperative endocrine treatment and 6.5% chemotherapy. No significant relationship between the presence or concentrations of oestrogen or progesterone receptor and the disease-free interval was observed. It is therefore possible that the positive relationship between these variables reported in some investigations reflects an influence by adjuvant endocrine measures.
AuthorsA Alanko, E Heinonen, T M Scheinin, E M Tolppanen, R Vihko
JournalBritish journal of cancer (Br J Cancer) Vol. 50 Issue 5 Pg. 667-72 (Nov 1984) ISSN: 0007-0920 [Print] England
PMID6498064 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Estrogen
  • Receptors, Progesterone
Topics
  • Breast Neoplasms (analysis, pathology, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Mastectomy
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prognosis
  • Receptors, Estrogen (analysis)
  • Receptors, Progesterone (analysis)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: